Patents by Inventor Colin Yee

Colin Yee has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20210308358
    Abstract: Doxorubicin is extracted from blood using anionic material, such as a resin comprising sulfonated polystyrene divinylbenzene beads, and polyethersulfone membrane, or both. After exposing the resin and/or membrane to blood in order to remove doxorubicin therefrom, the doxorubicin maybe extracted from the resin and/or membrane by exposing the material to an extraction solution, sonicating the extraction solution to enhance release of the doxorubicin, and repeating the exposure and sonication in order to remove substantially all of doxorubicin from the resin.
    Type: Application
    Filed: June 21, 2021
    Publication date: October 7, 2021
    Inventors: Karthik Raman, Colin Yee, Chia-Hung Sze, Arthur John Lockhart, David Barry
  • Patent number: 11071812
    Abstract: Doxorubicin is extracted from blood using anionic material, such as a resin comprising sulfonated polystyrene divinylbenzene beads, and polyethersulfone membrane, or both. After exposing the resin and/or membrane to blood in order to remove doxorubicin therefrom, the doxorubicin maybe extracted from the resin and/or membrane by exposing the material to an extraction solution, sonicating the extraction solution to enhance release of the doxorubicin, and repeating the exposure and sonication in order to remove substantially all of doxorubicin from the resin.
    Type: Grant
    Filed: May 30, 2017
    Date of Patent: July 27, 2021
    Assignee: PENUMBRA, INC.
    Inventors: Karthik Raman, Colin Yee, Chia-Hung Sze, Arthur John Lockhart, David Barry
  • Publication number: 20170340797
    Abstract: Doxorubicin is extracted from blood using anionic material, such as a resin comprising sulfonated polystyrene divinylbenzene beads, and polyethersulfone membrane, or both. After exposing the resin and/or membrane to blood in order to remove doxorubicin therefrom, the doxorubicin maybe extracted from the resin and/or membrane by exposing the material to an extraction solution, sonicating the extraction solution to enhance release of the doxorubicin, and repeating the exposure and sonication in order to remove substantially all of doxorubicin from the resin.
    Type: Application
    Filed: May 30, 2017
    Publication date: November 30, 2017
    Applicant: Penumbra, Inc.
    Inventors: Karthik Raman, Colin Yee, Chia-Hung Sze, Arthur John Lockhart, David Barry